| Financial Year |
March 31 2023 |
| Monetary Funds |
2,683,433,437.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
201,331,526.44 |
| Accounts Receivable |
861,812,255.49 |
| Advances to Suppliers |
218,621,972.25 |
| Other Receivables |
1,278,032,720.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
35,042,756.18 |
| Dividend Receivable |
86,601,385.71 |
| Inventories |
646,028,563.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,316,208.44 |
| Other Current Assets |
167,053,488.28 |
| Total Current Assets |
6,136,801,245.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,451,035.70 |
| Long-term Equity Investment |
1,666,114,499.04 |
| Investment Properties |
234,401,808.95 |
| Fixed Assetes |
2,049,295,828.06 |
| Under-construction Projects |
662,288,749.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
204,439,953.73 |
| R&D expenses |
-- |
| Goodwill |
12,428,299.80 |
| Long-Term Deferred and Prepaid Expenses |
27,695,197.64 |
| Deferred Income Tax Assets |
364,344,456.86 |
| Other Non-Current Assets |
44,891,686.51 |
| Sub-Total of Non-Current Assets |
5,303,201,714.13 |
| Total Assets |
11,440,002,959.62 |
| Short-Term Loans |
3,086,297,268.16 |
| Trading Financial liabilities |
4,769,530.28 |
| Notes Payable |
1,118,712,781.65 |
| Accounts Payable |
1,769,188,468.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,992,278.27 |
| Taxes Payable |
27,242,678.53 |
| Interest Payable |
29,182,502.00 |
| Dividend Payable |
452,791.83 |
| Other payables |
401,291,930.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
552,522,094.26 |
| Other Current Liabilities |
255,750,773.67 |
| Sub-Total of Current Liabilities |
7,526,920,254.68 |
| Long-term Loans |
272,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
257,808,975.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
119,636,465.81 |
| Deferred Income Tax Liabilities |
7,173,804.75 |
| Other Non-Current Liabilities |
301,620.77 |
| Sub-Total of Non-Current Liabilities |
677,702,155.31 |
| Total Liabilities |
8,204,622,409.99 |
| Paid-In Capital(Or Share Stock) |
4,479,532,523.00 |
| Capital Surplus |
824,688,686.47 |
| Surplus Reserve |
69,663,778.84 |
| LESS:Treasury Stock |
60,018,731.98 |
| Undistributed Profits |
-2,421,340,326.90 |
| Minority Stockholder's Interest |
344,432,353.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,890,948,196.62 |
| Owner's Equity（Stockholder's Equity） |
3,235,380,549.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,440,002,959.62 |
